Zhengye Biotechnology Hol...

NASDAQ: ZYBT · Real-Time Price · USD
6.70
-2.79 (-29.40%)
At close: Aug 21, 2025, 3:59 PM
6.53
-2.54%
After-hours: Aug 21, 2025, 07:05 PM EDT

Zhengye Biotechnology Balance Sheet Statement

Financials in CNY. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
18.6M 15.07M 9.75M 6.28M
Short-Term Investments
1.43M 1.22M n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
26.75M 6.5M 2.23M 13.17M
Receivables
88.52M 99.42M 134.25M 102.19M
Inventory
58.22M 58.3M 55.42M 43.62M
Other Current Assets
2K 24.03M 12.46M 11.14M
Total Current Assets
177.57M 205.59M 214.31M 164.94M
Property-Plant & Equipment
255.16M 271.5M 283.67M 255.12M
Goodwill & Intangibles
22.78M 16.3M 19.46M 12.05M
Total Long-Term Assets
315.68M 294.3M 305.37M 280.33M
Total Assets
493.25M 499.89M 519.67M 445.28M
Account Payables
42.96M 45.66M 79.28M 77.57M
Deferred Revenue
3.69M 3.98M 4.7M 4.28M
Short-Term Debt
81.63M 79.86M 54.89M 30M
Other Current Liabilities
3.28M n/a n/a n/a
Total Current Liabilities
135.91M 150.23M 152.23M 125.63M
Long-Term Debt
4.8M 9.99M 9.99M n/a
Other Long-Term Liabilities
n/a 393K 590K 816K
Total Long-Term Liabilities
4.8M 10.38M 10.58M 816K
Total Liabilities
140.71M 160.62M 162.81M 126.44M
Total Debt
86.43M 89.85M 64.88M 30M
Common Stock
8K 8K 8K 8K
Retained Earnings
48.15M 38.38M 65.77M 42.33M
Comprehensive Income
32.65M 31.31M 27.57M 21.99M
Shareholders Equity
283.96M 272.85M 296.5M 267.47M
Total Investments
1.43M 1.22M n/a n/a